TAF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.158600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.778600E-01
Normal-vs-Stage2
8.287800E-01
Normal-vs-Stage3
1.208560E-01
Normal-vs-Stage4
5.655600E-01
Stage1-vs-Stage2
9.215400E-01
Stage1-vs-Stage3
9.374300E-02
Stage1-vs-Stage4
3.639400E-01
Stage2-vs-Stage3
1.377160E-01
Stage2-vs-Stage4
2.186400E-01
Stage3-vs-Stage4
7.771600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.993000E-01
Normal-vs-AfricanAmerican
9.335600E-01
Normal-vs-Asian
7.349000E-01
Caucasian-vs-AfricanAmerican
8.289800E-01
Caucasian-vs-Asian
7.224800E-01
AfricanAmerican-vs-Asian
7.320800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.056800E-01
Normal-vs-Female
8.456200E-01
Male-vs-Female
8.038200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.426600E-01
Normal-vs-Age(41-60Yrs)
8.121400E-01
Normal-vs-Age(61-80Yrs)
6.500600E-01
Normal-vs-Age(81-100Yrs)
5.488000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.651200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.357600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.790600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.532410E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.436980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.728800E-01
Normal-vs-Daily Drinker
5.267400E-01
Normal-vs-Weekly Drinker
5.761200E-01
Normal-vs-Occasional Drinker
6.487400E-01
Normal-vs-Social Drinker
7.932400E-01
Non Drinker-vs-Daily Drinker
7.339800E-01
Non Drinker-vs-Weekly Drinker
9.938000E-01
Non Drinker-vs-Occasional Drinker
4.204200E-02
Non Drinker-vs-Social Drinker
5.941600E-01
Daily Drinker-vs-Weekly Drinker
7.872400E-01
Daily Drinker-vs-Occasional Drinker
4.523600E-02
Daily Drinker-vs-Social Drinker
4.605400E-01
Weekly Drinker-vs-Occasional Drinker
1.057400E-01
Weekly Drinker-vs-Social Drinker
6.406200E-01
Occasional Drinker-vs-Social Drinker
2.075400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.146200E-01
Normal-vs-Grade 2
1.755800E-01
Normal-vs-Grade 3
1.156960E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.082600E-01
Grade 1-vs-Grade 3
2.198400E-01
Grade 1-vs-Grade 4
3.146200E-01
Grade 2-vs-Grade 3
1.977040E-01
Grade 2-vs-Grade 4
1.755800E-01
Grade 3-vs-Grade 4
1.156960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.629800E-01
Normal-vs-NonDiabetic
7.173400E-01
Diabetic-vs-NonDiabetic
6.228000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.054000E-01
Normal-vs-NoPancreatitis
7.565400E-01
Pancreatitis-vs-NoPancreatitis
3.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.605000E-01
Normal-vs-N1
8.380600E-01
N0-vs-N1
7.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.110600E-01
Normal-vs-TP53-NonMutant
7.810000E-01
TP53-Mutant-vs-TP53-NonMutant
3.027700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
